42 results
F-1/A
IINN
Inspira Technologies Oxy B.H.N. Ltd
20 May 24
Registration statement (foreign) (amended)
4:02pm
for treatment of larger patient populations in and beyond ICU settings. The INSPIRA ART is being designed as a new intent of use for long-term (longer than
F-1
IINN
Inspira Technologies Oxy B.H.N. Ltd
9 May 24
Registration statement (foreign)
5:02pm
of use for long-term (longer than 6 hours) life support that provides assisted extracorporeal circulation and physiologic gas exchange (oxygenation
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
3 Apr 24
Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
8:56am
ventilation can cause harsh and long-term negative effects on neonates who require respiratory life support during the early and critical stages
424B5
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Apr 24
Prospectus supplement for primary offering
4:01pm
for long-term (longer than 6 hours) life support that provides assisted extracorporeal circulation and physiologic gas exchange (oxygenation and CO2 … as a new intent of use for long-term (longer than 6 hours) respiratory support that provides assisted extracorporeal circulation and physiologic gas
6-K
EX-99.1
dd9avywi7es8
12 Mar 24
Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
4:01pm
6-K
EX-99.1
sk84m22y6lxeh9la6
8 Mar 24
Notice of Extraordinary General Meeting of Shareholders
4:01pm
6-K
EX-99.1
pxf4cm9ob9p1u yj
4 Mar 24
Notice of Extraordinary General Meeting of Shareholders
4:01pm
6-K
EX-99.1
450z dw4m
30 Jan 24
Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices
8:40am
424B5
1qffjnss
28 Dec 23
Prospectus supplement for primary offering
9:28am
POS AM
yf7gonofirpt
10 Oct 23
Prospectus update (post-effective amendment)
5:00pm
6-K
EX-99.2
u3kecx ex43ftuvl
2 Oct 23
Interim Condensed Financial Statements
4:01pm
6-K
EX-1.1
bvnrhjwpaa
4 Apr 23
Report of Foreign Private Issuer
4:21pm
424B5
2a6rk1
4 Apr 23
Prospectus supplement for primary offering
4:19pm
POS AM
fnta00u77yn5pxe k0
13 Oct 22
Prospectus update (post-effective amendment)
4:01pm
6-K
EX-99.1
yirlkip
29 Sep 22
Interim Condensed Financial Statements
2:33pm
6-K
EX-99.2
umv0kgnd
29 Sep 22
Interim Condensed Financial Statements
2:33pm
6-K
EX-99.1
z7sjh fm67c
8 Sep 22
Notice of Annual and Extraordinary General Meeting of Shareholders
4:01pm